SCHEMBL4351322

SCHEMBL4351322

Cc1ccc(C=C2SC(NC(=O)Nc3cc(F)c(F)c(F)c3C)=NC2=O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 12/20 0.45
PRMT5 O14744 1/20 0.40
PRMT1 Q99873 1/20 0.40
MAPT P10636 5/20 0.39
CISD1 Q9NZ45 1/20 0.39
RAB9A P51151 2/20 0.39
KMT2A Q03164 4/20 0.37
MEN1 O00255 3/20 0.37
ALDH1A1 P00352 3/20 0.37
RECQL P46063 3/20 0.37
POLB P06746 2/20 0.37
GAA P10253 2/20 0.37
KDM4E B2RXH2 2/20 0.37
USP2 O75604 1/20 0.37
NSD2 O96028 1/20 0.37
HTT P42858 1/20 0.37
SYK P43405 1/20 0.37
BLM P54132 1/20 0.37
MCL1 Q07820 1/20 0.37
HPGD P15428 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4352766 0.92 ALOX5 (0.43) ALOX5PRMT5PRMT1MAPTCISD1
SCHEMBL14694010 0.81 ALOX5 (0.44) ALOX5MAPTRAB9AKMT2AMEN1
SCHEMBL4351314 0.78 ALDH1A1 (0.47) ALOX5MAPTRAB9AKMT2AMEN1
SCHEMBL4351318 0.78 ALDH1A1 (0.47) ALOX5MAPTRAB9AKMT2AMEN1
SCHEMBL4352758 0.75 EPHX2 (0.47) ALOX5MAPTRAB9AKMT2AMEN1
SCHEMBL4352759 0.75 EPHX2 (0.47) ALOX5MAPTRAB9AKMT2AMEN1
SCHEMBL6262619 0.69 ALOX5 (0.59) ALOX5PRMT5PRMT1MAPTRAB9A
SCHEMBL4352665 0.68 EPHX2 (0.52) ALOX5MAPTRAB9AKMT2AMEN1
SCHEMBL4351701 0.68 MEN1 (0.43) ALOX5MAPTRAB9AKMT2AMEN1
SCHEMBL6265185 0.67 ALOX5 (0.63) ALOX5MAPTRAB9AALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1890695-B1 USE OF 2,5-DISUBSTITUTED THIAZOL-4-ONE DERIVATIVES IN DRUGS GRUENENTHAL GMBH (DE) 2013-02-20 EP claimed
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs GRUENENTHAL GMBH (DE) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215758-A1 Use of 2,5-Disubstituted Thiazol-4-One Derivatives in Drugs ABCB1, ABCG2, SLC5A2 ALOX5 2623/4885PRMT5 2054/4885PRMT1 3776/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.